GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Price-to-Tangible-Book

Stealth BioTherapeutics (Stealth BioTherapeutics) Price-to-Tangible-Book : (As of May. 12, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Price-to-Tangible-Book?

As of today (2024-05-12), Stealth BioTherapeutics's share price is $0.32. Stealth BioTherapeutics's Tangible Book per Share of Mar. 2022 for the quarter that ended in Mar. 2022 was $-0.87. Hence, Stealth BioTherapeutics's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Stealth BioTherapeutics's Price-to-Tangible-Book or its related term are showing as below:

MITO's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.7
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Stealth BioTherapeutics's share price is $0.32. Stealth BioTherapeutics's Book Value per Sharefor the quarter that ended in Mar. 2022 was $-0.87. Hence, Stealth BioTherapeutics's P/B Ratio of today is .


Stealth BioTherapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Stealth BioTherapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Price-to-Tangible-Book Chart

Stealth BioTherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Price-to-Tangible-Book
Get a 7-Day Free Trial - - 6.88 - -

Stealth BioTherapeutics Quarterly Data
Dec16 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Stealth BioTherapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Stealth BioTherapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stealth BioTherapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stealth BioTherapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Stealth BioTherapeutics's Price-to-Tangible-Book falls into.



Stealth BioTherapeutics Price-to-Tangible-Book Calculation

Stealth BioTherapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2022 )
=0.32/-0.872
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Stealth BioTherapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Traded in Other Exchanges
N/A
Address
c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005
Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.

Stealth BioTherapeutics (Stealth BioTherapeutics) Headlines

From GuruFocus